» Articles » PMID: 34194520

(Rhamnaceae) Alleviates Working Memory Impairment and Restores Neurochemical Alterations in the Prefrontal Cortex of D-Galactose-Treated Rats

Overview
Date 2021 Jul 1
PMID 34194520
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is a progressive cognitive dysfunction. However, pharmacological treatments are symptomatic and have many side effects, opening the opportunity to alternative medicine. This study investigated the antiamnesic effect of the aqueous extract of on D-galactose-induced working memory impairment in rats. Impairment of working memory was induced by subcutaneous (s.c.) injection of D-galactose (350 mg/kg/day) to rats for 21 days. These animals were then subjected to object recognition and Y-maze tests. Rats with confirmed memory impairment were treated () with tacrine (10 mg/kg), aspirin (20 mg/kg, ), extract (41.5, 83, and 166 mg/kg, ), and distilled water (10 mL/kg, ) daily for 14 days. At the end of the treatments, alteration in working memory was assessed using the above paradigms. Afterward, these animals were euthanized, and cholinergic, proinflammatory, and neuronal damage markers were analyzed in the prefrontal cortex. Rats administered D-galactose and treated with distilled water had impaired working memory (evidenced by decreased time spent on the novel object and discrimination index) and decreased spontaneous alternation in the Y-maze. D-galactose also decreased the levels of acetylcholinesterase and acetylcholine and increased the level of glial fibrillary acidic protein, ionized calcium-binding adapter molecule 1, tumor necrosis factor-alpha (TNF-), interleukin 1 beta (IL-1), interleukin 6 (IL-6), and interferon-gamma (IFN-). Treatment with the extract (166 mg/kg) reversed the time spent on the novel object and the discrimination index. It equally increased the percentage of spontaneous alternation. Neurochemical analysis revealed that the extract markedly alleviated acetylcholinesterase activity and neuroinflammation. These observations were corroborated by the reduction in neuronal loss. Taken together, these results suggest that aqueous extract possesses an antiamnesic effect. This effect seems to involve cholinergic and anti-inflammatory modulations. This, therefore, claims using this plant in the treatment of dementia in Cameroon subject to further studies and trials.

Citing Articles

Kalanchoe crenata Haw. (Crassulacea) Decreases Hippocampal Neuron Loss and Improves Memory and Executive Function in Aged Rats: Implications for Anti-Inflammatory and Antioxidant Mechanisms.

Kandeda A, Mezui C, Kengni S, Baldagai N, Mabou S Brain Behav. 2025; 15(2):e70261.

PMID: 39957048 PMC: 11830630. DOI: 10.1002/brb3.70261.


Insights into bioactivity guided chemical profiling of Mill. fruits wild-growing in Montenegro.

Perovic T, Lazovic B, Adakalic M, Dzamic A, Zarkovic L, Gasic U Heliyon. 2025; 11(1):e41361.

PMID: 39811273 PMC: 11730539. DOI: 10.1016/j.heliyon.2024.e41361.


Polyphenol-enriched fraction from a Chinese herbal compound granule protects against D-galactose-induced apoptosis and metabolic disorders in PC12 cells.

Wusiman Z, Maimaitiming B, Yasen R, Yizibula M Am J Transl Res. 2024; 16(10):5813-5828.

PMID: 39544751 PMC: 11558389. DOI: 10.62347/EGNA1218.


Ferulic Acid-Loaded Nanostructure Maintains Brain Levels of ACh, Glutamate, and GABA and Ameliorates Anxiety and Memory Impairments Induced by the D-Galactose Aging Process in Rats.

Rossato D, Rosa J, Fontoura M, de Souza L, de Almeida T, Kudrna K Neurochem Res. 2024; 49(12):3383-3395.

PMID: 39302597 DOI: 10.1007/s11064-024-04248-z.


Investigation of the Cognitive Activity Between the Leaf Extracts of Eclipta alba and Ziziphus jujuba in Diabetic Animal Models.

Annepaka E, Rangasmy M, Panakala S, Sayana S Cureus. 2024; 16(3):e55400.

PMID: 38562322 PMC: 10982838. DOI: 10.7759/cureus.55400.


References
1.
LITCHFIELD Jr J, WILCOXON F . A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949; 96(2):99-113. View

2.
Burgmans S, van Boxtel M, Smeets F, Vuurman E, Gronenschild E, Verhey F . Prefrontal cortex atrophy predicts dementia over a six-year period. Neurobiol Aging. 2008; 30(9):1413-9. DOI: 10.1016/j.neurobiolaging.2007.11.028. View

3.
Tuppo E, Arias H . The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol. 2004; 37(2):289-305. DOI: 10.1016/j.biocel.2004.07.009. View

4.
Birks J . Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006; (1):CD005593. PMC: 9006343. DOI: 10.1002/14651858.CD005593. View

5.
Imbimbo B, Lombard J, Pomara N . Pathophysiology of Alzheimer's disease. Neuroimaging Clin N Am. 2006; 15(4):727-53, ix. DOI: 10.1016/j.nic.2005.09.009. View